drugset / Trial / NCT03489161

Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal

NCT03489161

Phase 0 Completed 3 enrolled Virginia Commonwealth University
NaSingle-groupOpen-labelTreatment

Summary

The investigators are trying to determine whether they can effectively treat patients suffering from acute opioid withdrawal in the Emergency Department at Virginia Commonwealth University Health System (VCUHS) and subsequently transfer them to an outpatient addiction clinic within the existing infrastructure. This will be a descriptive investigation of the process to reveal areas of success and opportunities for improvement in order to determine feasibility of the study procedures in preparation for a larger clinical investigation.

Timeline

Start
2018-08-01
Primary completion
2018-08-28
Completion
2018-08-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 4 mg Subcutaneous
Subject Buprenorphine Other / unclassified 8 mg Subcutaneous
Background Naloxone Small molecule 1 mg Subcutaneous
Background Naloxone Small molecule 2 mg Subcutaneous